Hemophilia Management Market By Type (Hemophilia A, Hemophilia B) By Drug (Octocogalfa, Nonacogalfa, Desmopressin And Other Drugs) And By Region- Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts(2018-2023)

Hemophilia Management Market By Type (Hemophilia A, Hemophilia B) By Drug (Octocogalfa, Nonacogalfa, Desmopressin And Other Drugs) And By Region- Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts(2018-2023)

ID: 310 | Pages: 178 | April 2018 | Region: Global


Overview of the Market:
 Hemophilia Management Market was worth USD 5.35 billion in 2018 and estimated to be growing at a CAGR of 1.62%, to reach USD 5.8 billion by 2023. Hemophilia is a genetic disorder which impairs body`s ability to control blood clotting. Hemophilia usually occurs in males it is estimated that about 1 in 5000 males that are born each year contain hemophilia.

Hemophilia is categorized into three levels depending on its severity as severe, moderate and mild. About 80% of the hemophilia patients are considered to suffer from severe type. The worldwide incidence of hemophilia is estimated at more than 400,000 people. It is estimated that about 75% of the hemophilia patients do not receive adequate treatment.

Growing prevalence of the disease and increasing usage of recombinant product is expected to drive the market growth. Technological advancements and advancements in the novel coagulating factors and are also fuelling the growth of global Hemophilia Management market. Rising investments in Research and developments for hemophilia products is also driving the market growth. However lack of available medication, awareness of this disease and high cost of treatment are the major restraining factors in the market. Advancements in gene therapy and increasing number of drug  approvals for treatment of hemophilia provide immense growth opportunities in the market.

Global Hemophilia management market is segmented on the basis of type of hemophilia and type of drug. By type of hemophilia it is further sub segmented into Hemophilia A and Hemophilia B. Based on type of drug it is further sub segmented into Octocogalfa, Nonacogalfa, Desmopressin and other drugs. Hemophilia A is projected to have the highest growth rate driven by large number of patients suffering from hemophilia A

Geographical Analysis:
On the basis of geography Global hemophilia management market is analyzed under various regions namely North America, Europe, Asia-pacific, Latin America and Africa & Middle-East. North America is the largest market for hemophilia management accounting for approximately XX% due to high government support and the increasing number of patients suffering from hemophilia. Europe is the second largest market for hemophilia management. Asia-Pacific region is estimated to be the fastest growing region owing to its high population base and increasing healthcare expenditure. Latin America region provide lucrative opportunity for growth attributed to local government support and increasing focus of global players towards emerging economies.

Key Market Players in this Market: 

Some of the major companies discussed in the report are Biogen, Baxter International Inc., Pfizer Inc., Bayer Pharma AG, Novo Nordisk A/S, Grifols International SA, CSL Behring, Octapharma and Swedish Orphan Biovitrum AB

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 BY Type                                        

                                5.1.1 Hemophilia A                         

                                5.1.2 Hemophilia B                          

                5.2 By Drug                                        

                                5.2.1 Octocogalfa                            

                                5.2.2 Nonacogalfa                           

                                5.2.3 Desmopressin                       

                                5.2.4 Other drugs                            

  1. Geographical Analysis

                6.1 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.2 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                            

                                6.2.6 France                       

                6.3 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                         

                                6.3.5 South Korea                           

                                6.3.6 Australia                   

                6.4 Latin America                                             

                                6.4.1 Introduction                           

                                6.4.2 Brazil                          

                                6.4.3 Mexico                     

                                6.4.4 Argentina                

                6.5 Middle East & Africa                                               

                                6.5.1 Introduction                           

                                6.5.2 Middle-East                            

                                6.5.3 Africa                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 Biogen                                          

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Pfizer Inc.                                    

                8.3 Baxter International Inc.                                       

                8.4 Bayer Pharma AG                                    

                8.5 Novo Nordisk A/S                                    

                8.6 Grifols International SA                                         

                8.7 CSL Behring                                

                8.8 Octapharma                                               

                8.9 Swedish Orphan Biovitrum AB                                           

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

    Appendix                                                          

a) List of Tables

b) List of Figures

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Hemophilia Management Market By Region, From 2018 to 2023 (USD Million)
  2. Global Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  3. Global Hemophilia-A Market By Region, From 2018 to 2023 (USD Million)
  4. Global Hemophilia-B Market By Region, From 2018 to 2023 (USD Million)
  5. Global Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  6. Global Octocogalfa Market By Region, From 2018 to 2023 (USD Million)
  7. Global Nonacogalfa Market By Region, From 2018 to 2023 (USD Million)
  8. Global Desmopressin Market By Region, From 2018 to 2023 (USD Million)
  9. Global Other drugs Market By Region, From 2018 to 2023 (USD Million)
  10. North America Hemophilia Management Market By Region, From 2018 to 2023 (USD Million)
  11. North America Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  12. North America Hemophilia-A Market By Region, From 2018 to 2023 (USD Million)
  13. North America Hemophilia-B Market By Region, From 2018 to 2023 (USD Million)
  14. North America Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  15. North America Octocogalfa Market By Region, From 2018 to 2023 (USD Million)
  16. North America Nonacogalfa Market By Region, From 2018 to 2023 (USD Million)
  17. North America Desmopressin Market By Region, From 2018 to 2023 (USD Million)
  18. North America Other drugs Market By Region, From 2018 to 2023 (USD Million)
  19. United States Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  20. United States Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  21. Canada Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  22. Canada Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  23. Europe Hemophilia Management Market By Region, From 2018 to 2023 (USD Million)
  24. Europe Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  25. Europe Hemophilia-A Market By Region, From 2018 to 2023 (USD Million)
  26. Europe Hemophilia-B Market By Region, From 2018 to 2023 (USD Million)
  27. Europe Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  28. Europe Octocogalfa Market By Region, From 2018 to 2023 (USD Million)
  29. Europe Nonacogalfa Market By Region, From 2018 to 2023 (USD Million)
  30. Europe Desmopressin Market By Region, From 2018 to 2023 (USD Million)
  31. Europe Other drugs Market By Region, From 2018 to 2023 (USD Million)
  32. U.K Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  33. U.K Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  34. Spain Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  35. Spain Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  36. Germany Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  37. Germany Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  38. Italy Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  39. Italy Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  40. France Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  41. France Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  42. Asia-Pacific Hemophilia Management Market By Region, From 2018 to 2023 (USD Million)
  43. Asia-Pacific Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  44. Asia-Pacific Hemophilia-A Market By Region, From 2018 to 2023 (USD Million)
  45. Asia-Pacific Hemophilia-B Market By Region, From 2018 to 2023 (USD Million)
  46. Asia-Pacific Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  47. Asia-Pacific Octocogalfa Market By Region, From 2018 to 2023 (USD Million)
  48. Asia-Pacific Nonacogalfa Market By Region, From 2018 to 2023 (USD Million)
  49. Asia-Pacific Desmopressin Market By Region, From 2018 to 2023 (USD Million)
  50. Asia-Pacific Other drugs Market By Region, From 2018 to 2023 (USD Million)
  51. China Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  52. China Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  53. India Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  54. India Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  55. Japan Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  56. Japan Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  57. South Korea Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  58. South Korea Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  59. Australia Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  60. Australia Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  61. Latin America Hemophilia Management Market By Region, From 2018 to 2023 (USD Million)
  62. Latin America Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  63. Latin America Hemophilia-A Market By Region, From 2018 to 2023 (USD Million)
  64. Latin America Hemophilia-B Market By Region, From 2018 to 2023 (USD Million)
  65. Latin America Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  66. Latin America Octocogalfa Market By Region, From 2018 to 2023 (USD Million)
  67. Latin America Nonacogalfa Market By Region, From 2018 to 2023 (USD Million)
  68. Latin America Desmopressin Market By Region, From 2018 to 2023 (USD Million)
  69. Latin America Other drugs Market By Region, From 2018 to 2023 (USD Million)
  70. Brazil Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  71. Brazil Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  72. Argentina Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  73. Argentina Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  74. Mexico Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  75. Mexico Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  76. Middle East & Africa Hemophilia Management Market By Region, From 2018 to 2023 (USD Million)
  77. Middle East & Africa Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  78. Middle East & Africa Hemophilia-A Market By Region, From 2018 to 2023 (USD Million)
  79. Middle East & Africa Hemophilia-B Market By Region, From 2018 to 2023 (USD Million)
  80. Middle East & Africa Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  81. Middle East & Africa Octocogalfa Market By Region, From 2018 to 2023 (USD Million)
  82. Middle East & Africa Nonacogalfa Market By Region, From 2018 to 2023 (USD Million)
  83. Middle East & Africa Desmopressin Market By Region, From 2018 to 2023 (USD Million)
  84. Middle East & Africa Other drugs Market By Region, From 2018 to 2023 (USD Million)
  85. Middle East Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  86. Middle East Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
  87. Africa Hemophilia Management Market By Type, From 2018 to 2023 (USD Million)
  88. Africa Hemophilia Management Market By Drug, From 2018 to 2023 (USD Million)
Middle East & Africa Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, ...
Latin America Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Seroton...
Asia Pacific Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotoni...
Europe Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotonin-nore...
North America Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Seroton...
Bipolar Disorder Market By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder) By Mechanism Of Action (Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotonin-norepinephr...
Middle East and Africa Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables...
Latin America Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Asia-Pacific Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrume...
Europe Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), ...
North America Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), End Use...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.